Li Ren
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Virology 20
- HIV Research and Treatment 20
-
- HIV/AIDS drug development and treatment 11
- Co-authors
- Yiming Shao (12 shared papers)Jianqing Xu (3 shared papers)Chao Qiu (3 shared papers)Haijing Wang (4 shared papers)Zheng Wang (1 shared paper)Yanmin Wan (2 shared papers)Dan Li (1 shared paper)Zhiqiang Liu (3 shared papers)
- Journals
- Molecular Immunology (2 papers)Vaccine (2 papers)PLoS ONE (2 papers)Virus Research (1 paper)Cellular and Molecular Immunology (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Li Ren
30 papers receiving 245 citations
Peers
Comparison fields: 5 of 52
- Virology 92
- Immunology 87
- Infectious Diseases 62
- Emergency Medicine 20
- Epidemiology 65
Countries citing papers authored by Li Ren
This map shows the geographic impact of Li Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ren more than expected).
Fields of papers citing papers by Li Ren
This network shows the impact of papers produced by Li Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ren. The network helps show where Li Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 45 | |
| 2 | 2021 | 28 | |
| 3 | 2006 | 26 | |
| 4 | 2006 | 20 | |
| 5 | 2007 | 20 | |
| 6 | 2021 | 17 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 8 | |
| 9 | 2015 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2015 | 6 | |
| 13 | 2013 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2017 | 4 | |
| 18 | 2015 | 4 | |
| 19 | 2020 | 3 | |
| 20 | 2022 | 3 |
About Li Ren
Li Ren is a scholar working on Virology, Infectious Diseases, Immunology, Molecular Biology and Epidemiology, having authored 33 papers that have together received 252 indexed citations. Recurring topics across this work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (11 papers), Immune Cell Function and Interaction (8 papers), Plant Molecular Biology Research (4 papers), Herpesvirus Infections and Treatments (4 papers), Plant Reproductive Biology (3 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Virology (92 citations), Immunology (87 citations), Infectious Diseases (62 citations), Emergency Medicine (20 citations) and Epidemiology (65 citations). Li Ren has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Yiming Shao, Jianqing Xu, Chao Qiu, Haijing Wang, Zheng Wang, Yanmin Wan, Dan Li, Zhiqiang Liu, Xia Cui and Hua Liang. Their work appears in journals such as Molecular Immunology, Vaccine, PLoS ONE, Virus Research and Cellular and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.